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Supplementary Figure 1. Distribution of secondary metabolite biosynthetic potential across the three 
replicons of 64 B. ambifaria strains. Centre lines represent the median; box limits indicate the 25th and 75th 
percentiles; and whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles. Only 63 strains 
are represented by the box plot of replicon c3 due to the lack of a third replicon in B. ambifaria BCC1105. Boxplots 
were generated using the web tool BoxPlotR5. 
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Supplementary Figure 2. LC-MS data for observed and theoretical mass(es), and mass spectrum for each 
antimicrobial metabolite detected in screened B. ambifaria strains. (a) Bactobolins; (b) Pyrrolnitrin; (c) 
Enacyloxin IIa; (d) Hydroxyquinolines; and (e) Burkholdines. To profile the metabolites produced by each strain under 
agar-growth condition (see Methods), n = 1 LC-MS analysis per strain (10 strains examined) (Table 1). 
 
Supplementary Figure 2 (a) Bactobolins (A to D) 
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Supplementary Figure 2 (a) Bactobolins (E to H) 
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Supplementary Figure 2 (b) Pyrrolnitrin 
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Supplementary Figure 2 (c) Enacyloxin IIa 
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Supplementary Figure 2 (d) Hydroxyquinolines 
 
  
9 
 
Supplementary Figure 2 (e) Burkholdines 
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Supplementary Figure 3. High-resolution mass spectrometry analysis of B. ambifaria BCC0191 cepacin A. 
Measured spectra of cepacin A [M+H]+ (left) and [M+Na]+ (right). The generated molecular formulae for each species 
are shown and are in agreement with the molecular formula of cepacin A. n = 3 independent LC-MS analyses on 
agar grown cultures of strain BCC0191. 
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Supplementary Figure 4. Antimicrobial activity, HPLC chromatograms and presence/absence of cepacin-
related HPLC peaks for B. ambifaria wild-type (WT) and insertional mutants (::ccnJ). Antimicrobial activity 
against P. carotovorum, S. aureus, and P. ultimum; and HPLC chromatograms at 260 nm of the WT (see 
Supplementary Methods) and cepacin-deficient deriviatives of B. ambifaria strains (a) BCC0191, (b) BCC1252, and 
(c) BCC1241 are shown. The absence of cepacin production in the cepacin-deficient derivatives of B. ambifaria 
strains BCC0477, BCC1259 and BCC1218 was also confirmed by HPLC analysis. n = 2 biological replicates per 
overlay; and n = 2 HPLC analyses for each strain wild type and mutant. 
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Supplementary Figure 5. Comparative cepacin A metabolite analysis of the original producer strain B. diffusa 
LMG 029043 and B. ambifaria BCC0191. Extracted ion chromatograms at m/z 293.08 ± 0.02, corresponding to the 
[M + Na]+ ion of cepacin A, from LC-MS analyses of crude extracts from agar-grown cultures of B. ambifaria BCC0191 
(top), B. diffusa LMG 29043 (middle), and the insertional mutant B. ambifaria BCC0191::ccnJ (bottom). n = 1 
independent LC-MS analysis per strain/derivative. 
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Supplementary Figure 6. Impact of mutations on B. ambifaria BCC0191 antimicrobial activity and cepacin 
production. (a) Three mutants were compared to BCC0191 wild-type (WT): cepacin-deficient derivative (::ccnJ), 
third replicon knockout (Δc3), and a combined mutation (::ccnJΔc3). n = 2 independent overlays per condition, and 
the mean average used to generate the heat map. Scale represents change in zone of inhibition diameter (mm) 
compared to BCC0191 WT (red = reduced zone, white = no change, green = increased zone). (b) HPLC 
chromatograms at 260 nm of B. ambifaria BCC0191 WT and BCC0191Δc3 (n = 6 independent HPLC analyses per 
strain) highlighting the impact of third replicon deletion on cepacin production. 
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Supplementary Figure 7. Persistence of B. ambifaria BCC0191 and its third replicon mutant in models of 
infection.  
 
Galleria mellonella wax moth larvae model (a). Groups of 10 Galleria mellonella wax moth larvae, were injected 
in the last proleg on the right-side of the abdomen using a restraining technique as described6 (n = 30 larvae per 
condition). The larvae were incubated at 37°C for 72 hours, and their survival status was monitored periodically. 
Larvae were recorded as dead when they failed to respond to physical agitation. Centre bar represents the mean, 
and error bars represent standard deviation.  
 
Murine model of respiratory tract infection: (b) nasopharynx and (c) lung. Mice (n = 6 mice per time point) were 
infected via inhalation with a dose of 2 x 106 B. ambifaria BCC0191 (wild type) and its corresponding third replicon 
deletion mutant, BCC0191Δc3 (mutant), respectively. The mean number of colony forming units recovered from the 
nasopharynx (a) and lung (b) are shown after 24 hours, 48 hours and 5 days of infection. The centre bar represents 
the mean, and error bars represent the standard error. Persistence of the third replicon mutant after 24 hours in the 
lung was significantly lower than the wild type (** = P = 0.0038 in two-way ANOVA with Sidak's multiple comparisons 
test of wild type vs mutant). No colony forming units of the third replicon mutant were detected in the lungs of mice 
after 48 hours and 5 days of infection. 
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Supplementary Figure 8. PCR genotyping of B. ambifaria BCC0191 and BCC0191Δc3 recovered from the 
murine respiratory infection model. DNA was extracted from bacteria recovered from the murine infection model 
(n = 31 samples) using chelex-100 resin and random amplified polymorphic DNA (RAPD) fingerprinting PCR7 was 
performed (n = 1 independent PCR per sample) to validate their genetic identity. PCR products separated by agarose 
gel electrophoresis, and lanes are as follows: WT, strain BCC0191; Δc3, BCC0191Δc3; WT*, BCC0191 high quality 
DNA extracted using Maxwell16 instrument; 1, 17 and 23, BCC0191 WT colonies recovered from the nasopharynx 
of mice at 24 hours, 48 hours and 5 days of infection, respectively; 12, 21, and 31, BCC0191::Δc3 mutant colonies 
recovered from the nasopharynx of mice at 24 hours, 48 hours and 5 days of infection, respectively; and B, PCR 
blank with no template DNA. The gel is representative of RAPD PCR genotyping performed on the 31 bacterial 
samples archived post infection from the nasopharynx or lung (24 BCC0191 WT and 7 BCC0191 Δc3), and all 
colonies produced identical RAPD PCR profiles. 
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Supplementary Figure 9. Comparison of the gene organization for the Burkholderia cepacin A and Collimonas collimomycin BGCs. The predicted core biosynthesis 
genes are highly conserved between the pathways. The Collimonas BGC possesses several additional genes, mostly of hypothetical function, and the regulatory component 
upstream of the core biosynthetic genes differs between the two species. The sequence comparison image was constructed using the Python application Easyfig8. 
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Supplementary Figure 10. Rooted core-gene phylogeny of 64 B. ambifaria strains. The phylogenetic tree was constructed based on 1594 core genes identified and 
aligned using the software Roary9. The B. ambifaria root was determined by including the outgroup species, Burkholderia vietnamiensis G4. FastTree10 was used to construct 
the approximate-maximum-likelihood phylogeny using the generalised time reversible substitution model. The evolutionary distance scale bar represents the number of base 
substitutions per site. 
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Supplementary Table 1. B. ambifaria strains and genomes used during this study. 
Study Strain 
Name 
Alternative Name Source details Accession  No. 
or Bioproject 
Reference 
BCC0118 CEP0617; LMG P-24636 CF (Sputum); USA ERS784989 / 
BCC0191 HI 2345 (J82); ATCC 51993; ARS 
BcB 
ENV (Soil); USA 
ERS784799 11 
BCC0192 Ral-3; R-8863; HI2347; FC627 ENV (Corn rhizosphere, biocontrol strain); USA ERS785047 12 
BCC0197 ATCC 51671; LMG 19465; FC661; R-
9945; B37w 
ENV (Leaves of Sesbania exaltata, biocontrol 
strain) ERS785076 13 
BCC0200 Formally B.cepacia gv I (BC-B) ENV; USA ERS785045 11 
BCC0203 BCF/HG1-A; LMG-P 24640 ENV; USA ERS782625 14 
BCC0207 AMMD (LMG 19182T) ENV (Pea rhizosphere); USA PRJNA13490 12 
BCC0250 CEP0958;LMG P-24637; R-9927 CF (Sputum); Australia ERS784819 / 
BCC0267 LMG 19467; CEP0996; R-9935 CF (Sputum); Australia  ERS784835 12 
BCC0284 ATCC 53267; LMG 17829; CEP0102; 
C2965 
ENV (Corn roots); USA 
ERS1328916 12 
BCC0316 M54, HI 2347, R-5142 ENV (Soil); USA ERS784850 12 
BCC0338 ATCC 53266 LMG 17828; FC662 ENV (Corn roots); USA ERS1371637 12 
BCC0399 CEP1054 CF; USA ERS784860 / 
BCC0410 MVP/C1 64 ENV (Maize); Italy ERS784866 15 
BCC0423 MCI 4 ENV (Maize); Italy ERS1336067 16 
BCC0477 AU0216 CF (Sputum); USA ERS784882 / 
BCC0478 AU1366 CF (Sputum); USA ERS784897 / 
BCC0480 HI-2427 ENV (Soil); USA ERS784913 / 
BCC1041 MVP-C2-51 ENV (Maize); Italy ERS784930 15 
BCC1048 MVP-C2-69 ENV (Maize); Italy ERS784886 15 
BCC1052 MCll-68 ENV (Maize); Italy ERS1371632 17 
BCC1062 MDll-130riz ENV (Maize); Italy ERS1328829 18 
BCC1065 MDlll-B-388 ENV (Maize); Italy ERS784959 18 
BCC1066 MDlll-B-399 ENV (Maize); Italy ERS784800 18 
BCC1072 MDlll-P-170 ENV (Maize); Italy ERS1328913 18 
BCC1080 MDlll-T-2 ENV (Maize); Italy ERS1371635 18 
BCC1083 MDlll-T-50 ENV (Maize); Italy ERS1328835 18 
BCC1086 MDlll-T-401(s) ENV (Maize); Italy ERS1328827 18 
BCC1088 MDlll-T-474(s) ENV (Maize); Italy ERS1371633 18 
BCC1090 MVP-C1-40 ENV (Maize); Italy ERS1328833 15 
BCC1092 MVP-C1-53 ENV (Maize); Italy ERS784808 15 
BCC1093 MVP-C1-55 ENV (Maize); Italy ERS784821 15 
BCC1095 MVP-C1-80 ENV (Maize); Italy ERS784837 15 
BCC1098 MVP-C1-95 ENV (Maize); Italy ERS784852 15 
BCC1100 MVP-C2-25 ENV (Maize); Italy ERS784868 15 
BCC1103 MVP-C2-44 ENV (Maize); Italy ERS784884 15 
BCC1105 MVP-C2-73 ENV (Maize); Italy ERS1371636 15 
BCC1107 MVP-C2-79 ENV (Maize); Italy ERS784899 15 
BCC1212 MC40-6 ENV (Rhizosphere); USA PRJNA17411 / 
BCC1213 MC80-27 ENV; USA ERS1328957 / 
BCC1214 MA80-5 ENV; USA ERS784915 / 
BCC1216 MW20-13 ENV; USA ERS1328918 / 
BCC1218 MW80-16 ENV; USA ERS784932 / 
BCC1220 MS5-3 ENV; USA ERS1328837 / 
BCC1223 MS80-4 ENV; USA ERS784947 / 
BCC1224 KS0-1 ENV (Maize); USA ERS1328836 19 
BCC1228 KA20-1 ENV (Maize); USA ERS1328832 19 
BCC1229 KA5-1 ENV (Maize); USA ERS1371639 19 
BCC1233 KC0-24 ENV (Maize); USA ERS1328917 19 
BCC1236 KC5-54 ENV (Maize); USA ERS1328839 19 
BCC1237 KC10-16 ENV (Maize); USA ERS1371640 19 
BCC1240 KC311-11 ENV (Maize); USA ERS1328914 19 
BCC1241 KC311-6 ENV (Maize); USA ERS784961 19 
BCC1246 KC20-40 ENV (Maize); USA ERS1328834 19 
BCC1248 KW0-1; LMG-P 24641 ENV (Maize); USA ERS784801 19 
BCC1249 KW0-5 ENV (Maize); USA ERS1371634 19 
BCC1252 KW10-1 ENV (Maize); USA ERS784809 19 
BCC1256 KW420-19 ENV (Maize); USA ERS784823 19 
BCC1258 KW318-1 ENV (Maize); USA ERS1371641 19 
BCC1259 KW20-2 ENV (Maize); USA ERS784838 19 
BCC1265 MC40-7 ENV; USA ERS784854 / 
BCC1270 KC20-17 ENV (Maize); USA ERS784870 19 
IOP40-10 / ENV (Prairie grass rhizosphere) PRJNA20669 / 
MEX-5 / ENV (Teosinte plants (Zea perennis) PRJNA20667 / 
BCC0191 
::ccnJ 
/ / 
/ This study 
BCC1252 
::ccnJ 
/ / 
/ This study 
BCC1241 
::ccnJ 
/ / 
/ This study 
BCC0477 
::ccnJ 
/ / 
/ This study 
BCC1259 
::ccnJ 
/ / 
/ This study 
BCC1218 
::ccnJ 
/ / 
/ This study 
BCC0191Δc3 / / / This study 
BCC0191 
::ccnJΔc3 
/ / 
/ This study 
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Supplementary Table 2. B. ambifaria genomic statistics. 
 
Strain Total Contigs (Mbp) Mapped Contigs (Mbp) Total Contig No. Contigs <1000 bp N50 (bp) 
BCC0118 7.50 7.43 103 45 273879 
BCC0191 7.58 7.55 97 57 302202 
BCC0192 7.40 7.32 100 48 277504 
BCC0197 7.38 7.36 82 33 386867 
BCC0200 7.63 7.55 124 64 292321 
BCC0203 7.93 7.53 4 4 2669373 
BCC0207 7.53 7.48 4 4 2646969 
BCC0250 7.36 7.33 88 32 396147 
BCC0267 7.36 7.33 74 27 784052 
BCC0284 7.47 7.38 88 34 423851 
BCC0316 7.64 7.56 131 62 292321 
BCC0338 7.45 7.42 61 28 514723 
BCC0399 7.40 7.38 86 38 407605 
BCC0410 7.38 7.36 44 18 849830 
BCC0423 7.47 7.30 100 36 382759 
BCC0477 7.81 7.43 118 54 255598 
BCC0478 7.24 7.21 89 25 601161 
BCC0480 7.84 7.52 87 24 570779 
BCC1041 7.51 7.42 88 38 469567 
BCC1048 7.51 7.43 76 35 469249 
BCC1052 7.33 7.30 77 34 397259 
BCC1062 7.45 7.36 90 37 382455 
BCC1065 7.31 7.28 81 32 605534 
BCC1066 7.32 7.29 112 37 381533 
BCC1072 7.44 7.36 93 40 397405 
BCC1080 7.29 7.26 85 35 383339 
BCC1083 7.30 7.26 95 35 373328 
BCC1086 7.60 7.40 302 49 395516 
BCC1088 7.48 7.40 70 38 397405 
BCC1090 7.33 7.29 114 33 340920 
BCC1092 7.38 7.36 57 20 849686 
BCC1093 7.40 7.38 91 37 427669 
BCC1095 7.40 7.38 79 34 407577 
BCC1098 7.38 7.37 48 15 849506 
BCC1100 7.40 7.37 91 37 407581 
BCC1103 7.40 7.37 77 38 427387 
BCC1105 6.30 6.13 50 15 1592784 
BCC1107 7.40 7.37 83 39 374059 
BCC1213 7.47 7.42 107 40 425516 
BCC1214 7.61 7.14 169 79 270842 
BCC1216 7.46 7.33 166 73 234327 
BCC1218 7.46 7.42 109 51 348377 
BCC1220 7.64 7.14 188 74 393412 
BCC1223 7.61 7.14 157 80 267383 
BCC1224 7.27 7.19 152 53 360040 
BCC1228 7.38 7.35 82 33 558864 
BCC1229 7.51 7.48 100 51 298531 
BCC1233 7.96 7.42 126 75 390415 
BCC1236 7.63 7.58 123 47 358767 
BCC1237 7.34 7.31 91 32 420767 
BCC1240 7.40 7.37 63 29 503900 
BCC1241 7.68 7.44 138 61 288780 
BCC1246 7.48 7.44 72 32 450462 
BCC1248 8.03 7.50 273 132 241997 
BCC1249 7.58 7.55 71 27 447443 
BCC1252 7.42 7.38 107 60 254705 
BCC1256 7.54 7.47 104 49 281063 
BCC1258 7.60 7.52 110 57 272850 
BCC1259 7.63 7.30 162 75 431727 
BCC1265 7.62 7.29 136 50 335885 
BCC1270 7.60 7.53 115 51 315858 
IOP40-10 7.69 6.88 629 571 24355 
MC40-6 7.64 7.34 4 4 2769414 
MEX-5 7.86 6.58 706 634 20649 
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Supplementary Table 3. De-replicated secondary metabolite gene clusters of B. ambifaria. 
 
Cluster Type (antiSMASH prediction) Prevalence in B. ambifaria 
(out of 64 genomes) 
Average length (kbp)a,b 
Replicon c1   
Terpene 1 65c 20.9 
NRPS 1 64 54.5 
Arylpolyene 1 64 41.2 
NRPS 2 44 46.8 
PKS 1 28 47.6 
Lantipeptide 1 10 27.1 
Butyrolactone 1 1 11.0 
Terpene 2 1 21.0 
   
Replicon c2   
Homoserine lactone 1 64 20.6 
Phosphonate 64 41.7 
Terpene 3 64 21.1 
Other 1 64 41.1 
Terpene 4 64 24.0 
Bacteriocin 1 55 13.1 
Arylpolyene 2 53 44.9 
Ectoine 1 53 10.4 
Ectoine 2 38 10.4 
Homoserine lactone (cepacin-associated) 2 22 20.7 
Other 2 20 43.0 
Butyrolactone-otherKS 16 32.5 
Phenazine 13 20.4 
PKS 2 7 44.9 
NRPS 3 2 52.8 
Bacteriocin 2 1 25.9 
Arylpolyene 3 1 41.1 
   
Replicon c3   
Homoserine lactone 3 63 20.6 
Bacteriocin 3 63 10.8 
Terpene 5 63 22.0 
NRPS-T1PKS 1 54d 85.5 or 117.6e 
PKS 3 40 43.9 and 63.9f 
Other 3 34 27.0 
Butyrolactone 2 27 10.7 
Other 4 24 43.8 
NRPS-T1PKS 2 17 60.9 
Trans-AT-PKS 6 91.2 
   
Unknown genomic location   
NRPS 4 1 26.8 
Homoserine lactone 4 1 20.1 
NRPS-T1PKS-trans-AT-PKS 1 69.8 
 
Footnotes: 
a B. ambifaria strains MEX-5 and IOP40-10 were excluded from several cluster length averages due to the fragmented nature of 
clusters caused by lower quality genome assemblies. Other strains were excluded if the clusters were manually split from the 
antiSMASH predicted cluster. 
b Average length was calculated from predicted antiSMASH clusters or extracted sequences identified using BLAST; partial 
clusters were excluded. 
c B. ambifaria strain BCC1249 encoded a duplicate terpene 1 cluster. 
d B. ambifaria strains MEX-5, IOP40-10 and BCC1065 either possess low quality genomes preventing the reconstruction of the 
burkholdine NRPS-T1PKS pathway or encode a partial cluster. 
e The published NRPS-T1PKS pathway (85.5 kbp) was encoded by 36 B. ambifaria strains, while the larger 117.6 kbp pathway 
was encoded by 15 B. ambifaria strains and consists of the published pathway with additional biosynthetic genes. 
f The 43.9 kbp version of the pathway was encoded by 26 B. ambifaria strains, while the 63.9 kbp version was encoded by 14 B. 
ambifaria strains.  
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Supplementary Table 4. Known antimicrobial compounds produced by B. ambifaria. 
 
 
Footnotes: 
a Cepacin A biosynthetic gene cluster was identified during this study.  
Compound Prevalence in B. ambifaria Replicon Bioactivity activity 
Pyrrolnitrin 100% C2 Anti-fungal 
Burkholdine 84% C3 Anti-fungal 
AFC-BC11 53% C3 Anti-fungal 
Hydroxyquinolines 38% C3 Signaling molecule/Anti-fungal 
Cepacin Aa 34% C2 Anti-oomycetal/Anti-Gram-positive 
Bactobolins 27% C3 Anti-Gram-negative/Anti-Gram-positive 
Phenazine 20% C2 Anti-fungal 
Enacyloxin IIa 9% C3 Anti-Gram-negative 
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Supplementary Table 5. Antimicrobial susceptibility organisms: host and disease phenotypes1–4 and incubation temperatures. 
 
Organism  Source/ID Number  Incubation Temperature (°C)  Host Range  Disease  
Pathogenic bacteria and fungi         
Rhizobium radiobacter  LMG 187  30  Broad  Crown gall disease  
Pseudomonas savastanoi pv. 
phaseolicola  
LMG 2245  30  Common bean  Bean halo blight  
Dickeya solani  LMG 25993  30  European potato  Potato tuber rot  
Pectobacterium carotovorum  LMG 2464  30  Several crop species  Soft rot disease  
Pseudomonas syringae pv. tomato  LMG 5093  30  Tomato  Bacterial speck  
Xanthomonas campestris pv. 
campestris  
8004  30  Cultivated Brassicaceae  Black rot  
Pseudomonas syringae pv. 
syringae  
LMG 187  30  Common bean  Bacterial brown spot  
Burkholderia multivorans  ATCC 17616  30  Human (immunocompromised)  Opportunistic (e.g. CF lung 
infection)  
Staphylococcus aureus  NCTC 12981  37  Human  Multiple (cutaneous, systemic etc.)  
Enterococcus faecalis ATCC 51299 37  Human  Multiple (uninary, systemic etc.)  
Candida albicans  SC 5314  37  Human  Candidiasis  
Fusarium solani var. redolens 
(Wollenweber) 
MUCL 14241 22 Multiple crop species Root/foot rot, wilt 
Alternaria alternata (Fries:Fries) 
von Keissler 
MUCL 36 22 Several (pathovar specific) Black-spot, stem canker 
          
Other reference organisms         
Bacillus subtilis ATCC 23857 30 N/A N/A 
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Supplementary Table 6. Minimum Inhibitory Concentration (MIC) of enacyloxin IIa against plant and animal 
pathogens. 
 
Organism MIC (µg/ml) 
Rhizobium radiobacter 3.2 
Pseudomonas savastanoi pv. phaseolicola 50.0 
Dickeya solani 12.5 
Pectobacterium carotovorum 6.3 
Pseudomonas syringae pv. tomato 50.0 
Xanthamonas campestris pv. campestris 50.0 
Pseudomonas syringae pv. syringae 6.3 
Burkholderia multivorans 6.3 
 
Footnotes: 
MICs were measured in a microbroth dilution assay using iso-sensitest broth or TSB broth with doubling-dilutions of enacyloxin 
IIa between 100 and 0.098 µg/ml. Bacteria were grown for 18-24 hours and the optical density at 600 nm was measured. The 
MIC was determined by calculating the enacyloxin IIa concentration required to produce an 80% knockdown in optical density 
compared to the organism grown in the absence of the antibiotic; n = 3 replicates for MIC analysis. 
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Supplementary Table 7. The rhizocompetence of B. ambifaria BCC0191 and derived mutants.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Footnote: 
 
a The total viable counts of each replicate (n = 3 plants per condition) from BCC0191 wild-type and mutant derivatives 
cultured from 14 day colonised root segments and adjusted to 1 g fresh weight of root is shown. No B. ambifaria 
growth was detected on the control root segments.  
 
b Significant difference (P = 0.027, df = 4, t = -4.40, 95% confidence interval), between WT and Δc3 as determined 
by two-sided (unpaired) t-test assuming normally distributed data (Shapiro-Wilk test) and equal variances (Bartlett 
test). Failing these assumptions, the non-parametric Wilcoxon rank sum test was performed to determine 
significance. 
 
 
Replicate and Statistics Colony forming units per gram of root a  
WT ::ccnJ Δc3 
Replicate 1 3.1x107 1.0x107 9.0x106 
Replicate 2 1.7x107 7.9x106 1.1x107 
Replicate 3 3.6x107 2.1x108 5.4x106 
Meanb 2.8x107 7.8x107 8.5x106 
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Supplementary Table 8. Proteins with similarity to those encoded by the cepacin A biosynthetic gene cluster. 
Gene Name Length bp/aa Similar Proteins (excluding B. ambifaria) % aa Sequence 
Identity 
Proposed Function 
ccnA 714/237 LuxR family transcriptional regulator [Burkholderia vietnamiensis]  
LuxR family transcriptional regulator [Burkholderia contaminans]  
LuxR family transcriptional regulator [Burkholderia sp. USM B20] 
82% 
83% 
82% 
LuxR family transcriptional regulator 
ccnB 384/127 Hypothetical Protein [Burkholderia sp. LA-2-3-30-S1-D2] 
Hypothetical Protein [Burkholderia sp. RF2-non_BP3] 
Hypothetical Protein [Burkholderia sp. RF4-BP95] 
90% 
87% 
88% 
Hypothetical 
ccnC 654/217 GNAT family N-acetyltransferase [Burkholderia sp. LA-2-3-30-S1-D2] 
GNAT family N-acetyltransferase [Burkholderia sp. RF4-BP95] 
GNAT family N-acetyltransferase [Burkholderia contaminans] 
88% 
87% 
87% 
LuxI homoserine lactone synthase 
ccnD 1293/430 beta-ketoacyl-ACP synthase II [Burkholderia sp. LA-2-3-30-S1-D2] 
beta-ketoacyl-ACP synthase II [Burkholderia sp. RF4-BP95] 
beta-ketoacyl-ACP synthase II [Burkholderia sp. RF2-non_BP3] 
95% 
94% 
94% 
Beta-ketoacyl synthase 
ccnE 1386/461 NAD(P)/FAD-dependent oxidoreductase [Burkholderia contaminans] 
NAD(P)/FAD-dependent oxidoreductase [Burkholderia vietnamiensis]  
NAD(P)/FAD-dependent oxidoreductase [Burkholderia vietnamiensis]  
88% 
85% 
84% 
Flavin-dependent monooxygenase 
ccnF 1083/360 fatty acid desaturase [Burkholderia sp. LA-2-3-30-S1-D2] 
fatty acid desaturase [Burkholderia sp. RF4-BP95] 
fatty acid desaturase [Burkholderia vietnamiensis] 
92% 
92% 
89% 
Fatty acid desaturase 
(alkane hydroxylase) 
ccnG 1005/334 aromatic ring-hydroxylating dioxygenase subunit alpha [Burkholderia contaminans]  
aromatic ring-hydroxylating dioxygenase subunit alpha [Burkholderia sp. LA-2-3-30-S1-D2] 
Rieske (2Fe-2S) domain protein [Burkholderia vietnamiensis G4] 
95% 
94% 
94% 
Rieske non-heme iron-dependent 
oxygenase 
ccnH 876/291 hypothetical protein [Burkholderia contaminans] 
hypothetical protein [Burkholderia sp. LA-2-3-30-S1-D2] 
hypothetical protein [Burkholderia sp. RF2-non_BP3] 
86% 
82% 
81% 
Hypothetical 
  
ccnI 1419/472 MFS transporter [Burkholderia sp. LA-2-3-30-S1-D2] 
MFS transporter [Burkholderia sp. RF4-BP95] 
MFS transporter [Burkholderia sp. RF2-non_BP3] 
90% 
90% 
90% 
MFS transporter 
ccnJ 1797/598 AMP-dependent synthetase [Burkholderia contaminans] 
AMP-dependent synthetase [Burkholderia sp. RF4-BP95] 
AMP-dependent synthetase [Burkholderia vietnamiensis] 
88% 
86% 
85% 
Fatty acyl-AMP ligase 
ccnK 960/319 acyl-CoA desaturase [Burkholderia contaminans] 
acyl-CoA desaturase [Burkholderia sp. RF4-BP95] 
acyl-CoA desaturase [Burkholderia sp. LA-2-3-30-S1-D2] 
92% 
93% 
92% 
Fatty acid desaturase 
ccnL 984/327 acyl-CoA desaturase [Burkholderia contaminans] 
acyl-CoA desaturase [Burkholderia sp. RF4-BP95] 
acyl-CoA desaturase [Burkholderia sp. RF2-non_BP3] 
96% 
95% 
94% 
Fatty acid desaturase 
ccnM 321/106 polyketide synthase [Burkholderia sp. RF2-non_BP3] 
polyketide synthase [Burkholderia sp. LA-2-3-30-S1-D2] 
polyketide synthase [Burkholderia vietnamiensis] 
96% 
95% 
95% 
Acyl carrier protein 
ccnn 1098/365 fatty acid desaturase [Burkholderia contaminans] 
fatty acid desaturase [Burkholderia stagnalis] 
fatty acid desaturase [Burkholderia stagnalis] 
94% 
92% 
91% 
Fatty acid desaturase 
ccnO 924/307 delta-12-desaturase [Burkholderia sp. LA-2-3-30-S1-D2] 
delta-12-desaturase [Burkholderia vietnamiensis] 
delta-12-desaturase [Burkholderia contaminans] 
87% 
86% 
87% 
Thioesterase 
ccnP 186/61 rubredoxin [Burkholderia vietnamiensis] 
rubredoxin [Burkholderia contaminans] 
rubredoxin [Burkholderia stagnalis] 
95% 
93% 
92% 
Rubredoxin 
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Supplementary Table 9. Primers used during this study. 
 
Primersa Final Product Size Primer Use Source 
Fwd: 5’- GCG TCT AGA GAC GTG ATC ATT GCC GGA AA -3’ 
Rev: 5’- GCG GAA TTC TTG CCC GAT ACA TAG AGC GT -3’ 
707 Amplify product from fatty AMP 
ligase-encoding gene, ccnJ 
This study 
Fwd: 5’- TTA YTT TTG YGC CGC TAC MG -3’ 
Rev: 5’- CCM GAG CAG CTY TAT ACG AT -3’ 
582 Screen for presence of c3 replicon 
in B. ambifaria BCC0191Δc3 
(degenerate for B. ambifaria) 
This study 
Fwd: 5’- AAG AAA TCT GCT GCC GCT TG -3’ 
Rev: 5’- CAC TTC GCT GTA CCT CAA GC -3’ 
608 Screen for presence of pMinic3 in 
B. ambifaria BCC0191Δc3 
This study 
5’- AGC GGG CCA A -3’ Variable Random amplified polymorphic 
DNA genotyping 
Mahenthiralingam et al.7 
 
Footnotes: 
a Restriction sites in primer sequences are underlined. 
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Supplementary Notes 
 
Genome sequencing quality control and assembly. Illumina reads were trimmed using the wrapper 
script Trim Galore v0.4.220, which utilises Cutadapt v1.1221, and their quality assessed using FastQC 
v0.10.122. FLaSH v1.2.1123 was used to merge overlapping short read pairs to improve contiguity of 
assembled genomes. The resulting overlapped and paired-end reads output from FLASH were assembled 
into contigs using the assembler SPAdes v3.9.124. Misassembled contigs were identified and corrected 
with Pilon v1.2125. Contig sequences representing contaminating DNA were identified with Kraken 
v0.10.5-beta26 using the Minikraken database and removed prior to genomic analyses. Genome sequence 
quality assessment and statistics were calculated using QUAST v4.427. 
 
B. ambifaria genomics and in silico definition of specialized metabolite biosynthetic gene clusters. 
AntiSMASH analysis28 and BLAST29 searches for known specialized metabolite biosynthetic gene clusters 
(BGCs) detected a total of 1,272 BGCs across 64 B. ambifaria strains, defining a mean of 20 pathways 
per genome. Eighteen classes of metabolites were identified as well as one distinct BGC that was not 
recognised as encoding a previously reported metabolite class by antiSMASH, but was recognised as 
having the potential to direct the production of a specialized metabolite (there were 20 examples of this 
BGC in the genome set; see Figure 2). A combination of Kmer-matching and gene topology comparisons 
enabled de-replication of the 1,272 BGCs to 38 distinct putative BGCs (Figure 2; Supplementary Table 3). 
Of the 38 distinct BGCs, three singleton pathways were detected in contigs that had no significant 
homology to the reference sequences, and could not be incorporated into the assembled replicons c1, c2 
and c3 (Figure 2; Supplementary Table 3). 
 
The specialized metabolite encoding capacity of the replicons relative to their size (density) varied 
significantly (Supplementary Figure 1). The largest replicon (c1) possessed the lowest specialized 
metabolite BGC density, whereas the smallest replicon (c3) possessed the largest density. The metabolite 
BGC density of the replicons was not static across the B. ambifaria dataset, with replicon c3 varying in 
BGC density from less than 10% to above 30% (mean 19.4%; Supplementary Figure 1). Replicons c1 and 
c2 displayed a lower mean BGC density and density variance compared to c3. B. ambifaria strains 
encoded 3-6 BGCs on replicon c1, with eight distinct BGCs identified on the replicon. Replicon c2 encoded 
8-11 BGCs with 17 distinct BGCs; and c3 encoded 4-9 BGCs with eleven distinct BGCs detected. 
 
Of the 38 distinct BGCs, three singleton pathways were detected in contigs that had no significant 
homology to the reference sequences, and could not be incorporated into the assembled replicons c1, c2 
and c3 (Figure 2; Supplementary Table 3). One of BGC encoded a hybrid non-ribosomal peptide 
synthetase trans-acyltransferase polyketide synthase (NRPS-trans-AT PKS), and showed 92% sequence 
similarity to the malleilactone biosynthetic gene cluster30,31. The two remaining BGCs with unknown 
genomic locations were an uncharacterised NRPS in strain MEX-5, and a LuxRI system in strain IOP40-
10. The most frequently detected specialized metabolite classes were terpenes (5/38) and NRPS (4/38). 
Eleven of the distinct BGCs were encoded by all 64 B. ambifaria strains, and included four terpene 
synthase BGCs and two LuxRI systems (Figure 2). Eight clusters were detected in less than 5% of the B. 
ambifaria strains examined (<3 strains), three of which were type 1 modular PKS gene clusters (Figure 2). 
 
Analysis of QS-regulated BGCs in B. ambifaria. The availability of the extensive B. ambifaria genome 
and BGC datasets enabled interrogation of QS regulatory genes with a focus on LuxR-encoding genes as 
the key BGC regulators. We detected 356 luxR homologues across the 64 B. ambifaria strains, 
representing 14 distinct protein phylogenetic clades (Figure 3). These clades included the following B. 
ambifaria LuxRI quorum sensing (QS) systems: the bafRI system32 (63 of 64 strains), the cepR2I2 
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system33 (61 of 64 strains), one functionally uncharacterised system (22 of 64 strains), and a QS system 
present only in B. ambifaria IOP40-10. Six LuxR clades were associated with BGCs encoding the following 
compounds or compound classes (Figure 3): ectoine, lantipeptide, butyrolactone, enacyloxin IIa, 
bactobolins and a putative BGC that was identified as directing cepacin biosynthesis (see Figure 4). The 
remaining LuxR clades flanked membrane transporter genes, a type 3 secretion system and four clades 
were associated with genes of unknown collective functions (Figure 3). 
 
Phenotypic analysis of B. ambifaria BCC0191, cepacin and third replicon mutants. Antimicrobial 
activity against the panel of plant and animal pathogenic bacteria and fungi, as well as further reference 
strains, was examined. The loss of cepacin A production in BCC0191::ccnJ resulted in loss of anti-Gram-
positive activity against Staphylococcus aureus, Enterococcus faecalis and Bacillus subtilis 
(Supplementary Figure 6), in addition to the loss of Pythium inhibition and the weak activity against certain 
Gram-negative bacteria (Figure 4b; Supplementary Figure 4). Deletion of the third replicon resulted in loss 
of antagonism against the fungal species Candida albicans, Fusarium solani and Alternaria alternata, but 
enhanced anti-Gram positive activity which correlated with a 2-fold increase in cepacin production seen in 
the BCC0191Δc3 mutant (Supplementary Figure 6). The double mutant, BCC0191::ccnJΔc3, lost all the 
antimicrobial phenotypes observed for the wild-type B. ambifaria BCC0191 (Supplementary Figure 6). The 
rhizocompetence of B. ambifaria BCC0191 WT, BCC0191::ccnJ and BCC0191Δc3 mutants was also 
evaluated to assess whether their effect on biological control of Pythium (Figure 5) was a consequence of 
reduced root colonisation (see Supplementary Methods). After 14 days of growth in the pea biological 
control model system (not containing P. ultimum), the wild-type and BCC0191::ccnJ colonised the 
rhizosphere at equivalent levels (P = 0.7; Supplementary Table 7). The BCC0191Δc3 mutant colonised 
the pea rhizosphere at a rate significantly lower (P = 0.027, df = 4, t = -4.40), but within 0.5 log of the mean 
wild-type level of 2.8 x 107 cfu/g root (Supplementary Table 7).  
 
Supplementary Discussion 
 
Pan-genomics and extensive specialized metabolite diversity. Genomic analysis across 64 B. 
ambifaria genomes revealed substantial diversity in gene content and predicted specialized metabolite 
BGCs; branching into five defined clades. Eleven of the 38 BGCs were encoded by all studied B. ambifaria 
strains, the remaining BGCs constitute the accessory specialized metabolite potential of B. ambifaria (see 
Figure 2). The large core and accessory metabolite potential in B. ambifaria compliments previous studies 
of the wider Burkholderia genus34. Similar in-depth, species-focussed BGC distribution analyses were 
conducted in three Salinospora species with previously unknown metabolite potential, but these were 
restricted to NRPS, PKS and fatty acid synthase pathways35. A more limited analysis (6 strains) was also 
conducted with Streptomyces albus genomes 36. Pan-genomic analysis of nine strains has been performed 
on the biocontrol species Pseudomonas putida 37, but a detailed correlation to their specialized metabolite 
biosynthetic capacity and protective properties, such as that reported in this study, was lacking. 
 
Multifaceted analysis of previously characterised biocontrol strains. We analysed the in vitro 
antimicrobial activity, specialized metabolite BGCs, and metabolite profiles of ten strains spanning the B. 
ambifaria core-gene phylogeny, including seven of the eight previously characterised biological control 
strains (Supplementary Table 1): AMMD (BCC0207), BC-F (BCC0203), J82 (BCC0191), M54 (BCC0316), 
Ral-3 (BCC0192), ATCC 53267 (BCC0284) and ATCC 53266 (BCC0338). Most of these biocontrol strains 
were initially characterised by agricultural and biotechnology companies as potent agents capable of 
suppressing multiple plant pathogens. Variation was observed in the antimicrobial BGC content of the ten 
strains. The presence of multiple BGCs encoding broad spectrum antimicrobials suggests a “built-in” 
redundancy to their biocontrol ability to suppress plant pathogens. Despite encoding antimicrobial BGCs, 
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there were several examples of non-producing BGCs under the experimental conditions used. The 
absence of these metabolites in encoding strains may be due to multiple factors such as the presence of 
BGC or regulatory mutations within these strains, the need for specific growth conditions to prime 
biosynthesis, or that BGC expression is activated by complex interactions such as contact with a 
competing organism or inter-kingdom signalling from the host plant. 
 
Effect of third replicon deletion on the pathogenicity of B. ambifaria BCC0191. For B. ambifaria 
strains such as AMMD, deletion of the third genomic replicon rendered the derived mutant, AMMDΔc3, 
attenuated in multiple virulence models and resulted in loss of anti-fungal activity38, but retained the ability 
to colonise the rhizosphere39. Our B. ambifaria BCC0191Δc3 mutant exhibited a non-significant reduction 
in biocontrol efficacy against P. ultimum (105: P = 0.22, t = -1.44, df = 4; 106: P = 0.22, t = -1.46, df = 4; 
107: P  = 0.16, , t = -1.73, df = 4; Figure 5b), but exhibited a significantly reduced rhizocompetence, with 
the number of viable bacteria per g of root an order of magnitude below that of the wild-type (P = 0.027, t 
= -3.40, df = 4; Supplementary Table 7). In contrast to AMMDΔc338, B. ambifaria BCC0191Δc3 retained 
virulence in a Galleria wax-moth larvae virulence assay (Supplementary Figure 7a), suggesting in strain 
BCC0191 Galleria virulence is mediated by factors encoded on the first and second replicons. However, 
corroborating the reduced pathogenicity observed for c3 replicon mutants in vertebrate models38, B. 
ambifaria BCC0191Δc3 was not able to persist within the lungs of infected mice (Supplementary Figure 
7c). At the equivalent infective dose (2 x106 bacteria), highly virulent respiratory pathogens such as 
Pseudomonas aeruginosa persist in the same murine infection model at log-fold higher densities in both 
nasopharynx and lung40,41. In addition, no B. ambifaria was detected within the spleens of infected mice 
suggesting that the capability of this species for invasive infection, observed during fatal “cepacia 
syndrome” CF infection42, is low. 
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